ODP · As filed with the SEC
ODP cash flow statement, by quarter
The statement as ODP presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q3 2025 3 months ended Sep 27, 2025 | Q2 2025 3 months ended Jun 28, 2025 | Q1 2025 3 months ended Mar 29, 2025 | Q4 2024 3 months ended Dec 28, 2024 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net income (loss) | — | — | (29,000,000) | — |
| Loss from discontinued operations, net of tax | — | — | 0 | — |
| Net income (loss) from continuing operations | — | — | (29,000,000) | — |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | 27,000,000 | — |
| Charges for losses on receivables and inventories | — | — | 4,000,000 | — |
| Asset impairments | — | — | 38,000,000 | — |
| Compensation expense for share-based payments | — | — | 7,000,000 | — |
| Deferred income taxes and deferred tax asset valuation allowances | — | — | (15,000,000) | — |
| Changes in working capital and other operating activities | — | — | 25,000,000 | — |
| Net cash provided by operating activities of continuing operations | — | — | 57,000,000 | — |
| Net cash provided by operating activities | — | — | 57,000,000 | — |
| Cash flows from investing activities: | ||||
| Capital expenditures | — | — | (21,000,000) | — |
| Settlement of company-owned life insurance policies | — | — | 9,000,000 | — |
| Net cash used in investing activities of continuing operations | — | — | (12,000,000) | — |
| Net cash used in investing activities of discontinued operations | — | — | (2,000,000) | — |
| Net cash used in investing activities | — | — | (14,000,000) | — |
| Cash flows from financing activities: | ||||
| Payments on credit facilities and debt retirement | — | — | (219,000,000) | — |
| Borrowings under credit facilities | — | — | 201,000,000 | — |
| Net payments on other long and short-term borrowings | — | — | (3,000,000) | — |
| Share purchases for taxes, net of proceeds from employee share-based transactions | — | — | (2,000,000) | — |
| Other financing activities | — | — | (1,000,000) | — |
| Net cash used in financing activities of continuing operations | — | — | (24,000,000) | — |
| Net cash used in financing activities | — | — | (24,000,000) | — |
| Net increase (decrease) in cash, cash equivalents and restricted cash | — | — | 19,000,000 | — |
| Cash, cash equivalents and restricted cash at beginning of period | 182,000,000 | 190,000,000 | 171,000,000 | 197,000,000 |
| Cash, cash equivalents and restricted cash at end of period | 187,000,000 | 182,000,000 | 190,000,000 | 171,000,000 |
| Cash, cash equivalents and restricted cash at end of period — continuing operations | — | — | — | 171,000,000 |
| Supplemental information on non-cash investing and financing activities | ||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | — | — | 22,000,000 | — |
| Right-of-use assets obtained in exchange for new finance lease liabilities | — | — | 5,000,000 | — |
| Interest paid | — | — | 5,000,000 | — |
| Cash taxes paid, net | — | — | 4,000,000 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.